Atlas Trials

Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG

Clinical trial NCT01730417 · COMPLETED

Trial details

NCT number
NCT01730417
Sponsor
Bennett Chin
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neuroendocrine TumorsHeart Failure
Start date
2009-11-01
Primary completion
2011-06-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.